Attached files
file | filename |
---|---|
8-K - Conmed Healthcare Management, Inc. | v208300_8k.htm |
Exhibit
99.1
Jeffrey
W. Runge, MD, Former Chief Medical Officer for the Department of Homeland
Security, Appointed to Conmed Healthcare Management, Inc. Board of
Directors
Board
of Directors Increased to Six Members
Hanover, Md. -- (BUSINESS WIRE) —
January 18, 2011 -- Conmed Healthcare Management, Inc. (NYSE Amex: CONM -
News), a leading full service provider of correctional facility healthcare
services to county detention centers, today announced that the Company’s Board
of Directors has increased the size of the board to six members and appointed
Jeffrey W. Runge, MD to the Company’s board, effective immediately. Dr. Runge is
currently a Principal at The Chertoff Group, a firm providing advisory services
in business risk management, homeland security and homeland defense. He is also
the President and founder of Biologue, Inc., which provides consulting in
biodefense, medical preparedness and injury prevention and control.
"Dr.
Runge’s background and insights will be a valuable asset to our expanded board,”
commented Richard Turner, Chairman and Chief Executive Officer of Conmed. “We
welcome him to the board and look forward to having the benefit of his
perspective, guidance and counsel as we continue to work toward growing our
business and delivering shareholder returns over the long term. Dr.
Runge’s experience at the Department of Homeland Security (DHS) will be
increasingly important to Conmed’s relationships with those county detention
facilities that house detainees for Immigration and Customs Enforcement (ICE),
the principal investigative arm of DHS. Housing and proper care of
ICE detainees is an important part of the operational economics of many of our
community correctional facilities as well as prospective clients.”
From 2001
through August 2008, Dr. Runge served in the Bush administration, first as the
head of the National Highway Traffic Safety Administration, and, beginning in
September 2005, as the Department of Homeland Security’s first Chief
Medical Officer. Dr. Runge founded the DHS Office of Health Affairs in 2007 and
was confirmed by the Senate as DHS’s first Assistant Secretary for Health
Affairs in December 2007. Dr. Runge also served as Acting Department of Homeland
Security Undersecretary for Science and Technology from February through August
2006. In his role at DHS, Dr. Runge oversaw the operations of the Department’s
biodefense activities, medical preparedness and workforce health protection,
including managing DHS’s role in Project BioShield, working with the various
federal departments on medical countermeasure assurance. Prior to joining DHS,
Dr. Runge was Assistant Chairman of the Department of Emergency Medicine at the
Carolinas Medical Center in Charlotte, N.C., from 1984 through 2001. Dr. Runge
earned his medical degree from the Medical University of South Carolina and his
undergraduate degree from the University of the South. Dr. Runge has served as a
member of the Board of Directors of Pharmathene, Inc. since December
2009.
“I look
forward to serving on the Conmed Board of Directors,” commented Dr. Runge. “The
Company is dedicated to providing its customers innovative, cost-effective and
quality healthcare solutions for inmate populations; they value their employees
and are committed to strategies that grow the Company in quality and value for
its shareholders.”
About
Conmed
Conmed
has provided correctional healthcare services since 1984, beginning in the State
of Maryland, and currently serves county and municipal correctional facilities
in seven states, including Arizona, Kansas, Maryland, Oklahoma, Oregon, Virginia
and Washington. For more information, visit us at
www.conmedinc.com.
Forward
Looking Statements
This
press release may contain, among other things, certain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including, without limitation, (i) statements with respect to the Company's plans, objectives, expectations and
intentions; and (ii) other statements that are not historical facts including
statements which may be identified by words such as "may," "could," "would,"
"should," "believes," "expects," "anticipates," "estimates," "intends," "plans,"
"projects," "potentially," or similar expressions. These statements are based
upon the current beliefs and expectations of the Company's management and are
subject to significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. These forward-looking
statements involve certain risks and uncertainties that are subject to change
based on various factors (many of which are beyond the Company's control)
including, without limitation, the Company's ability to increase revenue and to
continue to obtain new contracts, contract
renewals and extensions; inflation exceeding the
Company’s projection of the inflation rate of cost of services under multi-year
contracts; the ability to obtain bonds; decreases in occupancy levels or
disturbances at detention centers; malpractice litigation; the ability to
utilize third party administrators for out-of-facility care; compliance with
laws and government regulations, including those relating to healthcare;
investigation and auditing of our contracts by government agencies; competition;
termination of contracts due to lack of government appropriations; material
adverse changes in economic and industry conditions in the healthcare market;
negative publicity regarding the provision of correctional healthcare services;
dependence on key personnel and the ability to hire skilled personnel; influence
of certain stockholders; increases in healthcare costs; insurance; completion
and integration of future acquisitions; public company obligations; limited
liability of directors and officers; the Company’s ability to meet the NYSE Amex
continued listing standards; and stock price volatility. More detailed
information about the Company and the risk factors that may affect the
realization of forward-looking statements is set forth in the Company’s filings
with the Securities and Exchange Commission, including the Company’s Annual
Report on Form 10-K filed with the SEC for
the fiscal year ended December 31, 2009.
Investors and security holders are urged to read this document free of charge on
the SEC's web site at www.sec.gov. The Company does not undertake to publicly
update or revise its forward-looking statements as a result of new information,
future events or otherwise.
Contact:
Conmed
Healthcare Management, Inc.
Thomas W.
Fry, 410-567-5529
Chief
Financial Officer
tfry@conmed-inc.com
or
Hayden
IR
Peter
Seltzberg, 646-415-8972
peter@haydenir.com
###